On May 29, 2020, the results of the study that “Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET over expression or MET amplification and acquired resistance to previous EGFR inhibitor”, led by Professor Wu Yilong of our hospital, were published online in ...

On a video conference held at 7:30 a.m. on May 8, Guangdong Provincial People's Hospital shared its experience in COVID-19 prevention and control with experts from Valley Health System (Valley Hospital) in the United States. The meeting was chaired by Yu Xueqing, President of Guangdong Provi...

Recently, Prof. Rufu Chen’s research group of our Pancreatic Center reported a research on the molecular mechanism that LncRNA-PLACT1 sustains activation of NF-κB pathway through a positive feedback loop with IκBα/E2F1 axis in pancreatic cancer. The relevant research results were published i...